Daix (France), Long Island City (New York, United States), June 3, 2022 - Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small
Investegate announcements from INVENTIVA, Inventiva announces the presentation of a scientific abstract at the 82nd Scientific Sessions of the American Diabetes Association